These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 3163271

  • 21. Enhancement by hemin of the sensitivity of K562 human leukemic cells to 1-beta-D-arabinofuranosylcytosine.
    Okabe-Kado J, Hayashi M, Honma Y, Hozumi M.
    Cancer Res; 1986 Mar; 46(3):1239-43. PubMed ID: 3455882
    [Abstract] [Full Text] [Related]

  • 22. Direct relationship of marrow cell growth and 1-beta-D-arabinofuranosylcytosine metabolism.
    Karp JE, Donehower RC, Dole GB, Burke PJ.
    Cancer Res; 1984 Nov; 44(11):5046-50. PubMed ID: 6488163
    [Abstract] [Full Text] [Related]

  • 23. Effects of 1-beta-D-arabinofuranosylcytosine incorporation on eukaryotic DNA template function.
    Kufe DW, Munroe D, Herrick D, Egan E, Spriggs D.
    Mol Pharmacol; 1984 Jul; 26(1):128-34. PubMed ID: 6431261
    [Abstract] [Full Text] [Related]

  • 24. Saturation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate accumulation in leukemia cells during high-dose 1-beta-D-arabinofuranosylcytosine therapy.
    Plunkett W, Liliemark JO, Adams TM, Nowak B, Estey E, Kantarjian H, Keating MJ.
    Cancer Res; 1987 Jun 01; 47(11):3005-11. PubMed ID: 3471322
    [Abstract] [Full Text] [Related]

  • 25. Enhancement of the toxicity and DNA incorporation of arabinosyl-5-azacytosine and 1-beta-D-arabinofuranosylcytosine by cyclopentenyl cytosine.
    Grem JL, Allegra CJ.
    Cancer Res; 1990 Nov 15; 50(22):7279-84. PubMed ID: 1699659
    [Abstract] [Full Text] [Related]

  • 26. Potential for selective enhancement of the in vivo metabolism of 1-beta-D-arabinofuranosylcytosine in rats by thymidine pretreatment.
    Danhauser LL, Rustum YM.
    Cancer Res; 1985 May 15; 45(5):2002-7. PubMed ID: 3986756
    [Abstract] [Full Text] [Related]

  • 27. Formation of 1-beta-D-arabinofuranosylcytosine diphosphate choline in cultured human leukemic RPMI 6410 cells.
    Lauzon GJ, Paran JH, Paterson AR.
    Cancer Res; 1978 Jun 15; 38(6):1723-9. PubMed ID: 274174
    [Abstract] [Full Text] [Related]

  • 28. Enhancement of the DNA breakage and cytotoxic effects of intercalating agents by treatment with sublethal doses of 1-beta-D-arabinofuranosylcytosine or hydroxyurea in L1210 cells.
    Minford J, Kerrigan D, Nichols M, Shackney S, Zwelling LA.
    Cancer Res; 1984 Dec 15; 44(12 Pt 1):5583-93. PubMed ID: 6208999
    [Abstract] [Full Text] [Related]

  • 29. Effect of the interval between high dose 1-beta-D-arabinofuranosylcytosine injections on leukemic cell load, intestinal toxicity, and normal hematopoietic stem cells in a rat model for acute myelogenous leukemia.
    Colly LP, Peters WG, Willemze R.
    Cancer Res; 1986 Aug 15; 46(8):3825-7. PubMed ID: 3460691
    [Abstract] [Full Text] [Related]

  • 30. Biochemical and cytokinetic modulation of L1210 and HL-60 cells by hydroxyurea and effect on 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity.
    Rauscher F, Cadman E.
    Cancer Res; 1983 Jun 15; 43(6):2688-93. PubMed ID: 6189585
    [Abstract] [Full Text] [Related]

  • 31. In vitro and in vivo studies of a promising antileukemic thymidine analogue, 5-hydroxymethyl-2' deoxyuridine.
    Kahilainen L, Bergstrom D, Kangas L, Vilpo JA.
    Biochem Pharmacol; 1986 Dec 01; 35(23):4211-5. PubMed ID: 3790149
    [Abstract] [Full Text] [Related]

  • 32. Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinofuranosylcytosine in leukemia and solid tumor cell lines.
    Bergman AM, Kuiper CM, Voorn DA, Comijn EM, Myhren F, Sandvold ML, Hendriks HR, Peters GJ.
    Biochem Pharmacol; 2004 Feb 01; 67(3):503-11. PubMed ID: 15037202
    [Abstract] [Full Text] [Related]

  • 33. In vitro pharmacodynamics of 1-beta-D-arabinofuranosylcytosine: synergy of antitumor activity with cis-diamminedichloroplatinum(II).
    Kern DH, Morgan CR, Hildebrand-Zanki SU.
    Cancer Res; 1988 Jan 01; 48(1):117-21. PubMed ID: 3334986
    [Abstract] [Full Text] [Related]

  • 34. Influence of fludarabine on pharmacokinetics and pharmacodynamics of cytarabine: implications for a continuous infusion schedule.
    Seymour JF, Huang P, Plunkett W, Gandhi V.
    Clin Cancer Res; 1996 Apr 01; 2(4):653-8. PubMed ID: 9816215
    [Abstract] [Full Text] [Related]

  • 35. Induction of internucleosomal DNA fragmentation in human myeloid leukemia cells by 1-beta-D-arabinofuranosylcytosine.
    Gunji H, Kharbanda S, Kufe D.
    Cancer Res; 1991 Jan 15; 51(2):741-3. PubMed ID: 1985792
    [Abstract] [Full Text] [Related]

  • 36. Cystathionine-beta-synthase cDNA transfection alters the sensitivity and metabolism of 1-beta-D-arabinofuranosylcytosine in CCRF-CEM leukemia cells in vitro and in vivo: a model of leukemia in Down syndrome.
    Taub JW, Huang X, Ge Y, Dutcher JA, Stout ML, Mohammad RM, Ravindranath Y, Matherly LH.
    Cancer Res; 2000 Nov 15; 60(22):6421-6. PubMed ID: 11103808
    [Abstract] [Full Text] [Related]

  • 37. Relationship of 1-beta-D-arabinofuranosylcytosine in plasma to 1-beta-D-arabinofuranosylcytosine 5'-triphosphate levels in leukemic cells during treatment with high-dose 1-beta-D-arabinofuranosylcytosine.
    Liliemark JO, Plunkett W, Dixon DO.
    Cancer Res; 1985 Nov 15; 45(11 Pt 2):5952-7. PubMed ID: 4053067
    [Abstract] [Full Text] [Related]

  • 38. The effect of 1-beta-D-arabinofuranosylcytosine on cell viability, DNA synthesis, and chromatid breakage in synchronized hamster fibrosarcoma cells.
    Jones PA, Baker MS, Benedict WF.
    Cancer Res; 1976 Oct 15; 36(10):3789-97. PubMed ID: 986242
    [Abstract] [Full Text] [Related]

  • 39. Deoxyguanosine enhancement of cytarabine nucleotide accumulation in human leukemia cells.
    Akman SA, Ross DD, Joneckis CC, Fox BM, Bachur NR.
    Cancer Treat Rep; 1985 Oct 15; 69(7-8):851-7. PubMed ID: 4016794
    [Abstract] [Full Text] [Related]

  • 40. The combination regimen of idarubicin and taxotere is effective against human drug-resistant leukemic cell lines.
    Majlessipour F, Avramis IA, Kwock R, Weinberg KI, Avrami VI.
    Anticancer Res; 2002 Oct 15; 22(3):1361-8. PubMed ID: 12168812
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.